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Summary: A radioimmunoassay for the measurement of 3,3'-diiodo-L-thyronine (rT2) in serum and amniotic fluid is
described. Specific antisera to rT2 were produced by immunization of rabbits with rT2 conjugated to bovine serum
albumin. The molar cross-reactivity tested for various iodothyronines and iodotyrosines was 0.3 % for triiodothyronine
and 0.001 % for thyroxine. The sensitivity of the assay with a detection limit of 1.8 fmol/tube (0.94 pg/tube) was due
to the high avidity of the antiserum and the use of 125I-labelled rT2 of maximum specific radioactivity. In most of
45 normal subjects, serum rT2 levels measured in evaporated ethanol extracts were below the detection limit of
0.018 nmol/1. Mean rT2 concentrations were 0.21 nmol/1 in newborn cord serum and 0.10 nmol/1 in amniotic fluid
at 12 to 30 weeks of pregnancy. The molar concentration ratio of 3,3',5'-triiodothyronine (rT3) to rT2 was estimated
to be 15.7 in cord serum of newborn. A similar rT3/rT2 ratio was found in adults after intravenous application of
500 Atg rT3. Using these data and the known rT3 values, a hypothetical mean serum rT2 concentration in adult normal
subjects of 0.015 nmol/1 was calculated. The radioimmunoassay described may be a useful analytical tool in studies of
the synthesis as well as the metabolism of thyroid hormones.
Radioimmunologische Bestimmung von 3,3'-Dijodthyronin in Serum und Fruchtwasser
Zusammenfassung: Es wird ein Radioiminunoassay zur Messung von 3,3'-Dijod-L-thyronin in Serum und Frucht-
wasser beschrieben. Spezifische Antiseren gegen rT2 wurden durch Immunisierung von Kaninchen mit rT2-Rinder-
seruinalbumin-Konjugaten gewonnen. Die molare Kreuzreaktivität, die für verschiedene Jodthyronine und -tyrosine
ermittelt wurde, betrug für Trijodthyronin 0,3%, für Thyroxin 0,001 %. Die hohe Empfindlichkeit der Methode
(Nachweisgrenze 1,8 fmol bzw. 0,94 pg pro Inkubationsprobe) beruht einerseits auf der hohen Avidität des verwen-
deten Antiserums, andererseits auf der Verwendung von 125J-markiertem rT2 mit maximaler spezifischer Radioaktivi-
tät. Zur radioimmunologischen Bestimmung wurden eingedampfte Ethanplextrakte von Serum- oder Fruchtwasser-
Proben eingesetzt. Die Konzentrationen von rT2 im Serum lagen in einem Kollektiv von 45 Normalpersonen zum
überwiegenden Teil unter der Nachweisgrenze der Methode von 0,018 nmol/1. In Seren aus Nabelschnurblut von Neu-
geborenen wurde ein mittlerer rT2-Spiegel von 0,21 nmol/1 gemessen. In Fruchtwasser aus der 12. bis 30. Schwanger-
schaftswoche lag die mittlere rT2 ^ Konzentration bei 0,10 nmol/1. Das molare Konzeiitrationsverhältnis von 3,3',5'-
Trijodthyronin (rT3) zu rT2 betrüg im Serum von Nabelschnurblut Neugeborener 15,7. Ein ähnliches rT3/rT2-Verhält-
nis würde im Serum Erwachsener nach intravenöser Applikation von 500 jug rT3 gefunden. Unter Benutzung dieser
Daten und der bekannten rT3-Werte ließ sich für erwachsene Normalpersonen eine hypothetische mittlere rT2-
Serumkonzentration von 0,015 nmol/1 berechnen. Die beschriebene Methode dürfte sich als nützlich für Unter-
suchungen sowohl der Synthese wie auch des Metabolismus von Schilddrüsenhormonen erweisen.
Introduction
The availability of radioimmunolpgical methods for the development of sensitive radioimmunoassays for 3,3',5'-
routine estimation of the thyroid hormones, triiodo- triiodothyronine (reverse T3, rT3) (1 , 2) have resulted in
thyronine (fa)1 and thyroxine (d), and the recent an intensification of studies on the peripheral conversion
— - ·— of T4 by monodeiodination. From these studies a series
^Abbreviations: rT2 = 3,3'-4uodp-I-thy*onine; T3 = 3,5,3'- of quantitative data on the conversion rates of T4 to T3
b = 3
 '
trUOd
°^
hyi0nme:
 (3, 4) and more recently on the peripheral generation of
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rT3 from T4 (5, 6) have become available. These kinetic
studies as well as recent investigations regarding the
thyroidal formation of iodothyronines (7) have stimu^
lated interest in analytical methods for the quantitative
determination of a further deiodination product of T4,
i. e. 3,3'-diiodothyronine (rT2).
This paper describes the methodology of a radioimmuno-
assay for rT2 as well as its application for rT2 determina-
tions in serum and amniotic fluid. Preliminary results
have been reported elsewhere (8). In the course of the
development of this method, two papers as abstracts
were published regarding a rT2 radioimmunoassay.
Chopra et al. (9) applied a rT2 radioimmunoassay to the
measurement of the in-vitro deiodination of T3 and rT3
added to liver homogenates. Earl et al. (10) investigated
the extrathyroidal formation of rT2 in athyreotic patients
receiving high doses of T4 over a long period. At present
no quantitative data are available concerning the natural
existence of rT2 in man.
Materials and Methods
Antisera
Antisera to 1X2 were produced in three rabbits immunized by
serial injections of a conjugate of rT2 to bovine serum albumin
in complete Freund^ adjuvant as described earlier for raising
antibodies to T3 and T4 (11,12). All immunized rabbits pro-
duced antisera satisfactory for radioimmunoassay of rT2. The
antiserum selected for use in the studies to be described was
obtained after three injections of the immunogen, eight weeks
after starting immunization. It was used in a final dilution of
1:180 000 in an incubation volume of 600 μΐ.
The rT2 conjugate to bovine serum albumin, all iodothyro-
nines and iodotyrosines used in this study were obtained by
courtesy of Henning Berlin GmbH.
Preparation of 12SI-labelled rT2
Labelled rT2 of maximum specific radioactivity was obtained
by radioiodination. of 3-iodo-L-thyronine with chloramin T.
3-io4o-irthyronine was dissolved in 0.01 mpl/1 sodium
hydroxide, chloramin T (Merck, Darmstadt) and sodium di-
sulfite in Q.I mql/l phosphate buffer pH 7,0. For labelling,
10 μΐ volumina of the following reagents were pipetted into
a microflex vial (Radiochemical Centre, Amersham) containing
40 μΐ 0.5 mol/l phosphate buffer pH 7.5:37 MBq (1 mCi) 125Iodine
(approximately 0.5 nmol iodine, Radiochemical Centre,
Amersham), 2 nmol 3-iodo-i-thyronine, 0.2 μιηοΐ chloramin T.
After an incubation period of 30 s, 1.5 μπιοί sodium disulfite
were added. The reaction mixture was transferred to a paper
strip (Whatman 3MM; 3 cm X 56 cm) and the labelled reaction
products were separated by descending preparative paper chrorria-
tography using iso-amylalcohol:n-hexane:2 mol/l ammonia
(volumes, 50 ml + 10 ml + 60 ml) as elution system (13). The
radioactivity distribution along the paper strip was estimated
using a paper and thin-layer scanner (D nnschichtscanner II,
Berthold, Wildbad). The paper segment corresponding to the
125l-rT2 peak was cut out and the labelled compound was
eluted with methanol containing 0.25% concentrated ammonia.
This solution was stored at - 20 °C. the radio chemical.purity
was tested by thin-layer chromatography (silica gel 60 F2s4
plates, Merck) in ethyl acetate:methanol:3 mol/l ammonia
(volumes, 50 ml + 20 ml + 10 ml). For use in the assay, the
methanol-ammonia eluate of labelled rT2 was directly diluted
with barbital buffer.
Preparation of test samples
Serum and amniotic fluid samples were extracted with two
parts of ethanol. 300 μΐ ethanol extract, which were equivalent
to 100 μΐ of original sample, were evaporated to dryness and
used for rT2 assay. The extraction yields were estimated to be
98.5% for serum and 100% for amniotic fluid. For recovery
experiments, known amounts of un labe lied rT2 were addded
to serum, which was then extracted in the routine way. Enrich-
ment of iodothyronines from serum was performed using
an ion-ex change resins (standard II columns, Bio-Rad, M nchen).
The columns were equilibrated with 3 ml 0.2 mol/l sodium
hydroxide. 5 ml serum was hydrolysed with 5 ml 0.2 mol/l
sodium hydroxide for 15 min and passed through the columns.
The columns were then washed two times with 5 ml of a solu-
tion of isppropanol and sodium acetate (Bio-Rad), two times
with 2.5 mol/l acetic acid and once with 0.5 ml glacial acetic
acid. The iodothyronines were eluted with 3 ml of glacial
acetic acid. The iodothyronine fraction was evaporated to
dryness by an air stream and the residue redissolved in 1 ml
barbital buffer. In this solution, tracer experiments yielded
a mean recovery of 64% of added labelled rT2. 200 μΐ samples,
which were equivalent to 1 ml of original serum, were pipetted
for rT2 assay. rT2-free serum samples prepared by charcoal
extraction were run in each set of enrichment experiments
to correct for blank effects.
Assay procedure
The rT2 assay was performed in 0.08 mol/l barbital buffer pH 8.6
containing 2 g/1 bovine serum albumin and 200 mg/1 sodium
azide. Reagents were incubated as follows: Evaporated serum or
amniotic fluid extract (representing 100 μΐ of original sample),
or 100 μΐ standard solution (from 1.8 to 914 fmol, i. e. 0.94 to
480 pg rT2), 100 μΐ tracer solution (containing 925 Bq (25 nCi)
corresponding to approximately 6 pg 125I-rT2 and 0.5 μΐ normal
rabbit serum), 100 μΐ antiserum to rT2 diluted 1:30 000, and
barbital buffer to give a final volume of 600 μΐ. After an incuba-
tion period of 1 to 3 hours at room temperature, 100 μΐ anti-
rabbit gammaglobulin serum (donkey) were added and incubated
at 4 °C over night. After centrifugati n, the precipitated radio-
activity was measured. Corrections were made for non-specific
binding which was usually between 1.5 and 2.5% of total activity.
All measurements were performed in triplicate.
rT3 measurements in serum and amniotic fluid were performed
by a modification of our ιΊ$ radioimmunoassay pub shed pre-
viously (2). rTa was directly estimated in 50 μΐ samples of serum
or amniotic fluid after inhibition of serum binding proteins
with 150 μg/tube and 100 μg/tube 8-anilino-l-naphthalene
sulfonic acid in the case of serum and amniotic fluid, respec-
tively. T3 and T4 were measured by radioimmunoassay as pre-
viously reported (11,12).
Results
Labelling
The paper chromatogram (fig. 1) shows a clear separa-
tion of the two major labelled products: rT2 with radio-
active iodine in 3'-position and double labelled rT3 with
125Iodine in 3'- and 5;-positiori of the iodothyronine
molecule. Free iodide migrates only a short distance in
this system. The Rf-values of the separated compounds
increase with the length of time the Chromatographie
system is in use and are therefore not listed. The radio-
chemical purity of carrier-free labelled rT2 was higher
than 99.5 % as tested by thinJayer chromatography
(fig. 1 inset). The labelled compound when stored in
πιβί1κιηο1^3ΐτιπκΗω solution at — 20 °C could be used for
some months without significant damage, Free iodine
impurity did not exceed 4% three months after labelling.
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Fig. 1. Separation of the reaction mixture after radioiodination
of 3-iodo-L-thyronine by preparative paper chromato-
graphy.
Inset: Thin-layer chromatogram of 125I-rT2 after elution
from paper.
Tab. 1. Relative molar cross-reactivity of iodothyronines and
iodotyrosines in the rT2 radioimmunoassay.
Compound
33'^ii°do-/,-thyronine (rT2)
3,5-diiodo-I-thyronine
SjS^'^triiodo-L-thyronine (T3)
3,3\5'-triiodo-/rthyronine (rT3)
,-thyroxine (T4)
3-iodo-Z,-tyrosine
3,5-diiodo-L-tyrosine
Molar
cross-reactivity
(%)
100
0.003
0.31
0.042
0.001
< 0.001
< 0.001
Methodology
Molar cross-reactivity values of the antiserum with
various iodpthyronines and iodotyrosines are pre-
sented in table 1. The cross-reactivity was assessed by
determining the molar amount of the analogue required
to cause a 50% displacement of labelled rT2 originally
bound. The highest cross-reactivity was observed for
T3 (0.31%). T4 demonstrated the lowest cross-reactivity
of the iodothyronines tested: 0.001% on a molar basis,
less than 0.001 % on a weight basis. The iodotyrosines
showed absolutely no cross^reaction effect up to 1 nmol/
tube. 4 nmöl/tube monoiodotyrosine and diiodotyrosine
caused only a slight depression of B/Bö values: 95 and
98%, respectively (fig. 2).
Scatchard plot analysis yielded an effective equilibrium
constant (14) of 2 X 1Ö10 1/mol. Due to this high avidity
of the chosen antiserum, a highly sensitive rT2 radio-
immunoassay could be established. The lower limit of
detection was 1.8 fmol/tube (0.94 pg/tübe). A 50%
inhibition of labelled rT2 bound to antibody was
achieved with 85 to 95 fmol/tube rf2 (45 to 50 pg/tube)
in five successive assays.
The mean recovery of unläbelled rT2 added to a normal
serum pool in amounts ranging from 0.036 to 4.60 nmol/1
serum was 103% (range 92 to 112%). Intra-assay repro-
ducibility was evaluated by ISfold determination of
serum from a normal volunteer having received exogenous
rT2 for kinetic studies and was found to be 38.8 ±3.0
fmol/tube (coefficient of variation 7.8%). The mean
inter-assay reproducibility of 6 samples in 5 successive
assays (mean rT2 between 56 und 148 fmol/tube) was
8.8% ranging from 5.6 to 14.5%.
Application to measurements in serum and
amniot ic fluid
The radioimmunoassay was applied to rT2 measure-
ments in serum and amniotic fluid. Table 2 presents
mean values and ranges of these estimates in serum
of normal subjects, in arterial cord serum of newborn
infants, and in amniotic fluid at early pregnancy stages.
rT3 values are also shown. Serum rT2 measured in 45
normal subjects in three different assays was below
the detection limit of 0.018 nmol/1 in approximately
80% of the collective. The upper range in sera with
measurable rT2 concentrations was 0.086 nmol/1 (0.045
jug/l). In biological fluids with high rT3 levels clearly
measurable rT2 concentrations were found. The mean
rT2 value in 39 newborn cord sera was 0.211 nmol/1
(0.11 Mg/1). The mean rT3 concentration of these
samples (3.13 nmol/1) is approximately ten times higher
than in serum of adult normal subjects. The mean rT2
level in amniotic fluids at 12 to 30 weeks of pregnancy
was found to be 0.100 nmol/1 (0.053 Mg/l). The mean
rT3 level in amniotic fluid of 3.21 nmol/1 is com-
parable with that in cord serum. T3 and T4 concen-
trations in amniotic fluid are very low (data not
shown).
The mean value of molar rT3/rT2 ratios in cord serum
was calculated to be 15.7. The mean rT3/rT2 ratio in
amniotic fluid was 38.1 with single values showing a
wide distribution between 3.0 and 86.
After tenfold enrichment of iodothyronines by anion-
exchange resins, we have found a mean rT2 concentra-
tion of 0.074 nmol/1 (0.039 g/l) in five normal sera.
rT2 determination in the same non-enriched sera yielded
rT2 values slightly above the detection limit of 0.018
nmol/1. For control experiments, known amounts of
unläbelled rT2 were added to rT2-free serum and normal
serum prior to enrichment. The recovery of rT2 in these
samples after enrichment was between 88 and 104%.
Preliminary results regarding the kinetics of rT2 in man
were obtained by the measurement of serum rT2 after
a bulk injection of 950 nmol (500 Mg) rT2 intravenously.
The curve in figure 3 demonstrates the disappearance of
imrnunoassayable rT2 from serum in one normal volun-
teer. A rapid rate of rT2 elimination from serum within
the first hour is followed by a constant disappearance
rate up to 6 hours after injection. During this period
rT2 concentration in serum decreased to approximately
.0.1 % of the value measured 5 min after injection. From
J. Clin. Chem. Clin. Biochem. / VoL 15,1977 / No. 8
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Tab. 2. Concentrations of rT2 and 1X3 in serum and amniotic fluid. Range = extreme values.
Number
Normal subjects (serum) 45
Newborn (cord serum) 39
Amniotic fluid at 1 2 to 26
30 weeks of pregnancy
Mean ± SD
Range
Mean ± SD
Range
Mean ± SD
Range
rT2(nmol/1)
< 0.01 8
< 0.018
0.211
0.095
0.100
0.051
rT3(nmol/1)
- 0.086
± 0.062
- 0.324
± 0.052
- 0.276
0.31
0.06
3.13
1.66
3.21
0.92
± 0.14
-0.63
± 0.78
-4.90
± 1.36
-5.96
rT3/rT2
ratio
—
15.7
8.9
38.1
3.0
± 4.9
-29.8
± 19.6
-86.4
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Fig. 2. Dose-response curves showing inhibition of binding of
12
 *Ι-ΓΤ2 by unlabelled iodothyronines and iodotyrosines
(MIT = 3-iodo-L-tyrosine, DIT = 3,5-diiodo-L-tyrosine).
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Fig. 3. Disappearance of immunoassayable rT2 from serum of
one normal volunteer after intravenous application of
500 Mg rT2.
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Fig. 4. Disappearance of rT3 and rT2 from serum of three normal
volunteers after intravenous application of 500 Mg rT3.
The inset shows the mean values of rT3/rT2 ratios. The
ranges about each medium point indicate the upper and
lower value of measurements taken on the three subjects.
tr tions after normalization to 70 kg body weight
within 5 hours post rT3 injection. The inset presents
mean rT3/rT2 ratios determined from the elimination
curves. These ratios decrease rapidly from 92 to
approximately 14 within 2 hours, then remain con-
stant during the next 3 hours. The mean ± standard
deviation of all single rT3/rT2 ratios between 2 and
5 hours after injection was calculated to be 14.3 ± 2.2.
the linear part of the elimination curve, the halftime of
rT2 in serum was estimated to be 1.2 hours in that person.
In a further experiment 770 nmol (500 Mg) rT3 were in-
jected into three normal V luiiteers. Serum concentra-
tions of rT3 as well as that of rT2 generated from rT3 by
peripheral deiodination were then measured by radi -
immunoassay. Figure 4 shows rT3 and rT2 serum concen-
Discussion
The presence of rT2 in thyroid tissue and plasma of
rats was first reported by Roche et al. (15) in 1955.
The method used in these early studies was based on
the paper Chromatographie separation of in-vivo labelled
iodothyronines after intravenous administration of
l3llodide in rats. Through the application of this techni-
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que it was found, that the relative rT2 concentration in
plasma was approximately 25 % of that of thyroxine.
T3 and rT3 were detected in much lower concentra-
tions. Although the existence of rT2 in the thyroid
gland of the rat could be confirmed (7), it appears that
the reported value of the relative rT2 concentration in
rat plasma is erroneously high. This is probably due to
artefacts in the two-dimensional paper chromatography.
From kinetic studies with radioactive labelled rT2 in
man it was concluded that due to its extremely short
biological halftime the presence of rT2 in human serum
would be very improbable (16). As a result of these
early studies it is evident that a direct quantitative deter-
mination of rT2 in biological fluids is only possible by
the use of a highly specific and highly sensitive analytical
method. The radioimmunoassay for rT2 described in
this paper satisfies these criteria.
By the immunization of three rabbits with rT2 conju-
gated to bovine serum albumin, antisera with high con-
centrations of antibodies to rT2 were obtained in two
animals, allowing final assay dilutions of 1:120 000 and
1:180 000, respectively. These high titres are compar-
able with that of antisera to T3 obtained previously
using the same immunization procedures (11), whereas
immunizations with 14 (12) and rT3 (2) conjugates to
bovine serum albumin yielded antisera with titres tenfold
lower. It seems likely that these differences in the immune
response may be due to the presence of only one iodine
atom in 3'-position in the case of rT2 and T3, and the pre-
sence of two iodines at the outer phenolic ring in the T4
and rT3 molecule.
The highest cross-reactivity of the antiseruin used for
rT2 assay was observed for T3 (0.31 %) reflecting again
the above mentioned similarities between rT2 and T3
with respect to chemical structure. A very low cross-
reactivity was found for T4 (0.001 %), which of all iodo-
thyronine components in biological material is generally
present in the highest concentration. Due to this low
cross-reactivity the measurement of rT2 in serum is not
influenced by T4. In the same manner, the absence of
cross-reactions with monoiodotyrosine and diiodotyrosine
exclude any interference of rT2 measurements in thyroid
tissue by these compounds.
The high sensitivity of this rT2 radioimmunoassay is a
consequence of the high avidity of the antiserum and the
use of labelled rT2 with maximum specific radioactivity.
We have found a twofold effective equilibrium constant
of rT2 antiserum in comparison to our rT3 radioimmuno-
assay (2). The lower limit of detection and the 50% inter-
cept are approximately half of that obtained in the rT3
assay.
The finding that rT2 measured by our method in uncon-
centrated serum samples was undetectable in most of
normal subjects, confirm the earlier speculations of
Stanbury & Morris (16) that serum rT2 levels in man
should be extremely low. In cord serum, however, clear-
ly increased rT2 levels with a mean value of 0.211 nmol/1
were found. Elevated rT2 concentrations (mean 0.100
nmol/1) compared to serum levels of adult normal sub-
jects were also observed in amniotic fluid at early pregancy
stages. In both cord serum and amniotic fluid, extremely
high rT3 concentrations accompanied by reduced T3 levels
have been recently reported (17,18,19).
The mean molar rT3/rT2 ratio in cord serum was found
to be 15.7. A similar ratio of 14.3 was observed in three
normal volunteers 2 to 5 hours after application of 500
§ rT3. In this experiment the rT3/rT2 ratio decreased
rapidly in the first 2 hours. This ratio remained constant
after the rT3 elimination curve showed a linear decrease,
indicating the equilibration of rT3 in its total distribu-
tion space. The comparability of the rT3/rT2 ratio found
in the kinetic experiment with that in cord serum suggest
that the peripheral deiodination rate of rT3 as well as the
degradation rate of rT2 are similar in normal persons and
newborn infants. This conclusion enables the calculation
of a hypothetical mean rT2 concentration in normal
subjects. Using the mean rT3 concentration of 0.31
nmol/1 measured in our normal collective and a rT3/rT2
ratio of about 15, one may calculate that the mean rT2
level in serum of normal adults should be approximately
0.015 nmol/1, a value slightly below our detection limit.
On the other hand, a mean rT2 value of 0.074 nmol/1
was measured in a limited number of normal sera after
iodothyronine enrichment. Several factors may be
responsible for this discrepancy. The accuracy of
measurements near the detection limit of a radio-
immunoassay is more or less influenced by protein
interferences of individual test sera, by the quality of
antigen-free serum and by other factors, even when
ethanolic serum extracts were assayed. In the case of
rT2-enriched test samples, it cannot be excluded that
artefacts due to anion-exchange chromatography con-
tribute to systematically elevated results. At present,
it is therefore not possible to specify a reliable mean
serum rT2 level in adult normal subjects. From our
results, however, it seems likely that this value should
be lower than 0.1 nmol/1.
It is at the present time not clear whether rT2 has any
physiological relevance. Therefore the usefulness of
the described method in clinical diagnostics is question-
able. However, the possibility for the quantitative
determination of rT2 may be qf importance for the
further clarification of peripheral thyroxine deiodination,
especially in kinetic and in vitro experiments.
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Addendum
After completion of this paper, a publication of Wu et al.
regarding a radioimmunoassay for the measurement of rT2 in
serum and amniotic fluid was brought to our attention (Wu, S. Y.,
Chopra, I. J., Nakamura, Y., Solomon, D. H. & Bennett, L. R.
(1976), J. Clin, Endocrinol. Metab. 43, 682-685).
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